Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

The SUUBI Program: Asset-Ownership for Orphaned Children in Uganda

Phase 1

Completed

Conditions: Poverty

First Posted Date: 2010-07-16

Last Posted Date: 2014-03-14

Lead Sponsor: Columbia University

Target Recruit Count: 286

Registration Number: NCT01163695

Locations: 🇺🇬
St. Joseph's Matale Parish, Rakai, Uganda

Electro-acupuncture for the Prevention of Taxane Induced Myalgias and Neuropathy

Not Applicable

Completed

Conditions: Breast Cancer
Neuropathy

Interventions: Device: Electro-acupuncture
Device: Sham acupuncture

First Posted Date: 2010-07-16

Last Posted Date: 2023-09-21

Lead Sponsor: Columbia University

Target Recruit Count: 63

Registration Number: NCT01163682

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Malaria and the Safety of Iron Supplements and Iron Fortification

Not Applicable

Completed

Conditions: Iron Deficiency

Interventions: Dietary Supplement: Ferrous sulfate

First Posted Date: 2010-07-05

Last Posted Date: 2015-02-12

Lead Sponsor: Columbia University

Target Recruit Count: 23

Registration Number: NCT01156896

Locations: 🇹🇭
Hospital for Tropical Diseases, Mahidol University, Bangkok, Thailand

HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.

Not Applicable

Completed

Conditions: HIV/AIDS
Sexually Transmitted Infections

Interventions: Behavioral: RESPECT-2 Counseling

First Posted Date: 2010-06-30

Last Posted Date: 2014-09-29

Lead Sponsor: Columbia University

Target Recruit Count: 5012

Registration Number: NCT01154296

Locations: 🇺🇸
Whitman-Walker Clinic, Washington, District of Columbia, United States
🇺🇸
Duval County Health Department, Jacksonville, Florida, United States
🇺🇸
Richland County Health Department, Colombia, South Carolina, United States

and more 6 locations

Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver

Phase 1

Completed

Conditions: Hepatitis B
Liver Transplantation

Interventions: Drug: Adefovir dipivoxil and hepatitis B vaccination

First Posted Date: 2010-06-22

Last Posted Date: 2021-08-10

Lead Sponsor: Columbia University

Target Recruit Count: 16

Registration Number: NCT01146808

Locations: 🇺🇸
Center for Liver Disease and Transplantation at Columbia University Medical Center, New York, New York, United States

FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health Record

Not Applicable

Completed

Conditions: Influenza

Interventions: Other: Provider Alert

First Posted Date: 2010-06-22

Last Posted Date: 2014-06-24

Lead Sponsor: Columbia University

Target Recruit Count: 6145

Registration Number: NCT01146899

Locations: 🇺🇸
Columbia University Medical Center/ NewYork Presbyterian Hospital Ambulatory Care Network, New York, New York, United States

Treatment Options for Protease Inhibitor-exposed Children

Phase 3

Completed

Conditions: HIV/AIDS
HIV Infections

Interventions: Drug: Abacavir (ABC)
Drug: Efavirenz (EFV)
Drug: Stavudine (D4T)
Drug: Lopinavir/ritonavir (LPV/r)

First Posted Date: 2010-06-22

Last Posted Date: 2017-03-13

Lead Sponsor: Columbia University

Target Recruit Count: 300

Registration Number: NCT01146873

Locations: 🇿🇦
Rahima Moosa Mother and Child Hospital, Johannesburg, Gauteng, South Africa

TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child Populations

Not Applicable

Completed

Conditions: Influenza

Interventions: Other: automated call
Other: Text Message

First Posted Date: 2010-06-22

Last Posted Date: 2015-10-07

Lead Sponsor: Columbia University

Target Recruit Count: 30537

Registration Number: NCT01146912

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Cognitive Dysfunction in Hypertensive Patients Having Spine Surgery

Completed

Conditions: Hypertension

Interventions: Procedure: Lumbar spine surgery
Other: Neurologic/neuropsychometric examinations

First Posted Date: 2010-06-10

Last Posted Date: 2015-06-04

Lead Sponsor: Columbia University

Target Recruit Count: 179

Registration Number: NCT01140854

Locations: 🇺🇸
Columbia University, New York, New York, United States

Rifaximin for the Treatment of Persistent Symptoms in Patients With Celiac Disease

Not Applicable

Completed

Conditions: Celiac Disease

Interventions: Drug: Placebo
Drug: Rifaximin

First Posted Date: 2010-06-07

Last Posted Date: 2022-06-29

Lead Sponsor: Columbia University

Target Recruit Count: 50

Registration Number: NCT01137955

Locations: 🇺🇸
Celiac Disease Center at Columbia University, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy